$ACHN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHILLION PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACHILLION PHARMACEUTICALS INC. Get notifications about new insider transactions in ACHILLION PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2020 | ACHN | ACHILLION PHARMACE ... | G1 EXECUTION SERVICES, LLC | 10% Owner | Sell | J | 6.30 | 14,115,498 | 88,927,637 | 0 | 14.1 M to 0 (-100.00 %) |
| Jan 30 2020 | ACHN | ACHILLION PHARMACE ... | G1 EXECUTION SERVICES, LLC | 10% Owner | Sell | J | 6.30 | 10,917 | 68,777 | 0 | 10.9 K to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 13.24 | 25,000 | 331,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 8.64 | 20,000 | 172,800 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 7.59 | 20,000 | 151,800 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | D | 3.10 | 50,000 | 155,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | D | 6.30 | 25,159 | 158,502 | 0 | 25.2 K to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | D | 6.30 | 3,393,382 | 21,378,307 | 0 | 3.4 M to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | D | 6.30 | 36,431 | 229,515 | 0 | 36.4 K to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Zelenkofske Steven | EVP, Chief Medical ... | Option Exercise | D | 2.18 | 200,000 | 436,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Zelenkofske Steven | EVP, Chief Medical ... | Option Exercise | D | 2.49 | 500,000 | 1,245,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 3.10 | 50,000 | 155,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | D | 7.59 | 20,000 | 151,800 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Sell | D | 6.30 | 40,000 | 252,000 | 0 | 40 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.18 | 1,097,000 | 2,391,460 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 2.90 | 419,000 | 1,215,100 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.02 | 200,000 | 604,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.10 | 87,766 | 272,075 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.66 | 30,000 | 109,800 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 3.78 | 632,000 | 2,388,960 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 4.11 | 185,000 | 760,350 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 7.59 | 100,000 | 759,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | D | 7.61 | 142,000 | 1,080,620 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | D | 6.30 | 3,500 | 22,050 | 0 | 3.5 K to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 3.10 | 50,000 | 155,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | D | 7.59 | 20,000 | 151,800 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Sell | D | 6.30 | 63,249 | 398,469 | 0 | 63.2 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Scheer David | Sell | D | 6.30 | 29,515 | 185,945 | 0 | 29.5 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | D | 4.11 | 135,000 | 554,850 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | D | 6.79 | 110,000 | 746,900 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | D | 2.18 | 150,000 | 327,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | D | 2.90 | 215,000 | 623,500 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Sell | D | 6.30 | 2,500 | 15,750 | 0 | 2.5 K to 0 (-100.00 %) |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 2.74 | 6,250 | 17,125 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 6.12 | 135,000 | 826,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Sell | D | 6.30 | 22,709 | 143,067 | 0 | 22.7 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Gibney Anthony S | EVP, Chief Business ... | Option Exercise | D | 2.18 | 200,000 | 436,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Gibney Anthony S | EVP, Chief Business ... | Option Exercise | D | 2.53 | 500,000 | 1,265,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 2.18 | 42,000 | 91,560 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 2.90 | 30,000 | 87,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 3.02 | 25,000 | 75,500 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 3.10 | 50,000 | 155,000 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 4.09 | 30,000 | 122,700 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 7.54 | 30,000 | 226,200 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | D | 7.59 | 20,000 | 151,800 | 0 | ||
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Sell | D | 6.30 | 1,500 | 9,450 | 0 | 1.5 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Sell | D | 6.30 | 90,000 | 567,000 | 0 | 90 K to 0 (-100.00 %) | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 2.18 | 200,000 | 436,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 3.32 | 400,000 | 1,328,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Di Donato Brian | SVP, Chief Financia ... | Option Exercise | D | 2.29 | 500,000 | 1,145,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Di Donato Brian | SVP, Chief Financia ... | Option Exercise | D | 2.56 | 200,000 | 512,000 | 0 | |
| Dec 19 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Option Exercise | M | 3.28 | 20,000 | 65,600 | 0 | ||
| Dec 19 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Buy | M | 3.28 | 20,000 | 65,600 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Nov 14 2019 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Option Exercise | M | 3.28 | 20,000 | 65,600 | 0 | ||
| Nov 14 2019 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Buy | M | 3.28 | 20,000 | 65,600 | 90,000 | 70 K to 90 K (+28.57 %) | |
| Nov 14 2019 | ACHN | ACHILLION PHARMACE ... | Scheer David | Option Exercise | M | 3.28 | 20,000 | 65,600 | 0 | ||
| Nov 14 2019 | ACHN | ACHILLION PHARMACE ... | Scheer David | Sell | S | 6.31 | 10,485 | 66,197 | 29,515 | 40 K to 29.5 K (-26.21 %) | |
| Nov 14 2019 | ACHN | ACHILLION PHARMACE ... | Scheer David | Buy | M | 3.28 | 20,000 | 65,600 | 40,000 | 20 K to 40 K (+100.00 %) | |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | M | 3.10 | 100,234 | 310,725 | 87,766 | |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | M | 3.28 | 33,250 | 109,060 | 0 | |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | S | 6.37 | 33,250 | 211,965 | 3,500 | 36.8 K to 3.5 K (-90.48 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Sell | S | 6.37 | 100,234 | 638,982 | 36,750 | 137 K to 36.8 K (-73.17 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Buy | M | 3.28 | 33,250 | 109,060 | 136,984 | 103.7 K to 137 K (+32.05 %) |
| Oct 18 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Buy | M | 3.10 | 100,234 | 310,725 | 103,734 | 3.5 K to 103.7 K (+2,863.83 %) |
| Feb 11 2019 | ACHN | ACHILLION PHARMACE ... | Di Donato Brian | Chief Financial Off ... | Option Exercise | A | 2.29 | 500,000 | 1,145,000 | 500,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Zelenkofske Steven | Chief Medical Offic ... | Option Exercise | A | 2.18 | 200,000 | 436,000 | 200,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 2.18 | 1,097,000 | 2,391,460 | 1,097,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | A | 2.18 | 150,000 | 327,000 | 150,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Lantz Keri | See Remarks | Option Exercise | A | 2.18 | 100,000 | 218,000 | 100,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Gibney Anthony S | Chief Business Offi ... | Option Exercise | A | 2.18 | 200,000 | 436,000 | 200,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 2.18 | 200,000 | 436,000 | 200,000 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | A | 2.18 | 42,000 | 91,560 | 42,000 | |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | M | 1.05 | 20,000 | 21,000 | 0 | |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Buy | M | 1.05 | 20,000 | 21,000 | 20,000 | 0 to 20 K |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | M | 1.05 | 20,000 | 21,000 | 0 | |
| Dec 18 2018 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Buy | M | 1.05 | 20,000 | 21,000 | 20,000 | 0 to 20 K |
| Sep 12 2018 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 3.32 | 400,000 | 1,328,000 | 400,000 | |
| Aug 21 2018 | ACHN | ACHILLION PHARMACE ... | Zelenkofske Steven | Chief Medical Offic ... | Option Exercise | A | 2.49 | 500,000 | 1,245,000 | 500,000 | |
| Aug 16 2018 | ACHN | ACHILLION PHARMACE ... | Gibney Anthony S | Chief Business Offi ... | Option Exercise | A | 2.53 | 500,000 | 1,265,000 | 500,000 | |
| Jun 08 2018 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | M | 1.05 | 20,000 | 21,000 | 0 | |
| Jun 08 2018 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Buy | M | 1.05 | 20,000 | 21,000 | 70,000 | 50 K to 70 K (+40.00 %) |
| Jun 04 2018 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 5,000 | 0 | 36,431 | 31.4 K to 36.4 K (+15.91 %) |
| Jun 04 2018 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
| May 03 2018 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Executive Off ... | Option Exercise | A | 3.78 | 632,000 | 2,388,960 | 632,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 2.90 | 640,000 | 1,856,000 | 640,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Option Exercise | A | 2.90 | 250,000 | 725,000 | 250,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | General Counsel | Option Exercise | A | 2.90 | 215,000 | 623,500 | 215,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Option Exercise | A | 2.90 | 419,000 | 1,215,100 | 419,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 2.90 | 30,000 | 87,000 | 30,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 2.90 | 30,000 | 87,000 | 30,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 2.90 | 30,000 | 87,000 | 30,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 2.90 | 30,000 | 87,000 | 30,000 | |
| Feb 13 2018 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | A | 2.90 | 30,000 | 87,000 | 30,000 | |
| Nov 22 2017 | ACHN | ACHILLION PHARMACE ... | JOHNSON & JOHNSON | 10% Owner | Sell | S | 2.75 | 18,367,346 | 50,510,202 | 0 | 18.4 M to 0 (-100.00 %) |
| Jun 30 2017 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Buy | W | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | VITULLO NICOLE | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Verwiel Frank | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Scheer David | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | KISHBAUCH MICHAEL D | Director | Option Exercise | A | 4.09 | 30,000 | 122,700 | 30,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Option Exercise | A | 4.11 | 458,000 | 1,882,380 | 458,000 | |
| Jan 19 2017 | ACHN | ACHILLION PHARMACE ... | Apelian David | Chief Medical Offic ... | Option Exercise | A | 4.11 | 185,000 | 760,350 | 185,000 | |
| Dec 23 2016 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Buy | P | 3.96 | 10,000 | 39,600 | 50,000 | 40 K to 50 K (+25.00 %) |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Truitt Joseph | Chief Commercial Of ... | Buy | P | 4.06 | 3,500 | 14,210 | 3,500 | 0 to 3.5 K |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | EVP, General Counse ... | Buy | P | 4.09 | 2,500 | 10,225 | 2,500 | 0 to 2.5 K |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Fenton Mary Kay | Chief Financial Off ... | Buy | P | 4.11 | 2,500 | 10,275 | 2,500 | 0 to 2.5 K |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Deshpande Milind | Chief Executive Off ... | Buy | P | 4.06 | 2,500 | 10,150 | 2,500 | 0 to 2.5 K |
| Dec 05 2016 | ACHN | ACHILLION PHARMACE ... | Barrish Joel C | Chief Scientific Of ... | Buy | P | 4.06 | 2,500 | 10,150 | 2,500 | 0 to 2.5 K |
| Feb 03 2016 | ACHN | ACHILLION PHARMACE ... | MANNING MARTHA E | EVP, General Counse ... | Option Exercise | A | 6.79 | 110,000 | 746,900 | 110,000 | |
| Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | FISHERMAN JASON S | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
| Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | FRASHIER GARY E | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 | |
| Jan 27 2016 | ACHN | ACHILLION PHARMACE ... | Graves Kurt | Director | Option Exercise | A | 7.54 | 30,000 | 226,200 | 30,000 |